Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-17-003868
Filing Date
2017-04-14
Accepted
2017-04-14 15:44:42
Documents
54
Period of Report
2017-02-28

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 360120
2 ex10-3.htm EX-10.3 3930
3 ex10-4.htm EX-10.4 5140
4 ex10-5.htm EX-10.5 83439
5 ex31.htm EX-31 12149
6 ex32.htm EX-32 5376
7 image_001.jpg GRAPHIC 15316
8 ex10-3_001.jpg GRAPHIC 113164
9 ex10-3_002.jpg GRAPHIC 138120
10 ex10-3_003.jpg GRAPHIC 170502
11 ex10-4_001.jpg GRAPHIC 121193
12 ex10-4_002.jpg GRAPHIC 142515
13 ex10-4_003.jpg GRAPHIC 138789
14 ex10-4_004.jpg GRAPHIC 192250
  Complete submission text file 0001493152-17-003868.txt   3535650

Data Files

Seq Description Document Type Size
15 XBRL INSTANCE FILE ptlf-20170228.xml EX-101.INS 300793
16 XBRL SCHEMA FILE ptlf-20170228.xsd EX-101.SCH 26038
17 XBRL CALCULATION FILE ptlf-20170228_cal.xml EX-101.CAL 33467
18 XBRL DEFINITION FILE ptlf-20170228_def.xml EX-101.DEF 66499
19 XBRL LABEL FILE ptlf-20170228_lab.xml EX-101.LAB 185454
20 XBRL PRESENTATION FILE ptlf-20170228_pre.xml EX-101.PRE 137295
Mailing Address 38 WEST MAIN STREET HANCOCK MD 21750
Business Address 38 WEST MAIN STREET HANCOCK MD 21750 844-473-8543
PetLife Pharmaceuticals, Inc. (Filer) CIK: 0001354591 (see all company filings)

EIN.: 331133537 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-52445 | Film No.: 17762868
SIC: 2860 Industrial Organic Chemicals